search
Back to results

Whole-body Electromyostimulation Versus Conventional Low-volume Strength Training in Overweight Individuals (EKAM)

Primary Purpose

Overweight and Obesity, Metabolic Syndrome

Status
Unknown status
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Control
Standard Strength Training
Low-volume Strength Training
Whole-Body Electromyostimulation (WB-EMS)
Sponsored by
University of Erlangen-Nürnberg Medical School
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Overweight and Obesity focused on measuring Exercise, Strength Training, Health Promotion, Inflammation, Body Composition

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Body Mass Index >25
  • presence of at least 2 cardiometabolic risk factors

Exclusion Criteria:

  • Healthy persons or patients under age
  • Overweight persons without any additional cardiometabolic risk factors
  • Pregnancy, Lactation
  • Psychological disorders, epilepsy, sever neurological disorders
  • Participation in other exercise- or nutrition studies within the last 6 months
  • acute cardiovascular disease
  • malignant disease
  • Rheuma
  • Intake of anabolic drugs,
  • Skin injuries in the area of electrode placements
  • Electronic implants (defibrillator, pacemaker)
  • Persons in mental hospitals by order of authorities or jurisdiction

Sites / Locations

  • Department of Medicine 1, Hector Center for Nutrition, Exercise and Sports,Recruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Experimental

Arm Label

Control

Standard Strength Training

Low-volume Strength Training

Whole-body Electromyostimulation

Arm Description

Nutritional therapy / no exercise

Nutritional therapy combined with a Standard Strength Training program

Nutritional therapy combined with a low-volume Strength Training program

Nutritional therapy combined with Whole-Body Electromyostimulation

Outcomes

Primary Outcome Measures

Metabolic Syndrome Z-Score (MetS-Z-Score)
MetS-Z-Score will be calculated from each individual's measures of waist circumference, mean arterial blood pressure, triglycerides, and HDL-cholesterol, based on equations specific to sex.

Secondary Outcome Measures

Muscle strength
Muscle strength of the five major muscle groups (chest, upper back, lower back, abdominals, legs) will be assessed by using specific strength-training devices (Butterfly, Pull-down, Hyperextension, Abdominal Crunch, Leg-Press)
Body Composition
Muscle mass, fat mass and body water will be measured by Bioelectrical Impedance Analysis (BIA)
Cardiorespiratory Fitness (CRF)
CRF will be assessed by measuring Maximum Oxygen uptake (VO2max)
Inflammation status
Inflammation will be assessed by measuring Levels of CRP and inflammatory cytokines and other inflammatory blood markers
Health-related quality of life
Health-related quality of life will be assessed by using the standardized and validated EQ-5D-5L Questionnaire
Pain scores
Pain scores will be assessed by using the standardized and validated Chronic Pain Grade Questionnaire (CPGQ)
Perceived stress
Perceived stress will be assessed by using the standardized and validated Perceived Stress Questionnaire (PSQ)
Subjective work ability
Subjective work ability will be assessed by using the standardized and validated Work Ability Index Questionnaire (WAI)

Full Information

First Posted
September 27, 2017
Last Updated
October 15, 2018
Sponsor
University of Erlangen-Nürnberg Medical School
search

1. Study Identification

Unique Protocol Identification Number
NCT03306056
Brief Title
Whole-body Electromyostimulation Versus Conventional Low-volume Strength Training in Overweight Individuals
Acronym
EKAM
Official Title
Comparison of the Effects of Whole-body Electromyostimulation Versus Conventional Low-volume Strength Training in Overweight Individuals at Increased Cardiometabolic Risk
Study Type
Interventional

2. Study Status

Record Verification Date
October 2018
Overall Recruitment Status
Unknown status
Study Start Date
November 1, 2017 (Actual)
Primary Completion Date
September 30, 2020 (Anticipated)
Study Completion Date
September 30, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Erlangen-Nürnberg Medical School

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The main purpose of this study is to compare the effects of whole-body electromyostimulation versus a conventional low-volume strength-training program, each combined with an individualized, weight-reducing diet, on the cardiometabolic risk profile, muscle strength, body composition, inflammatory markers and subjective health outcomes in overweight individuals at increased cardiometabolic risk.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Overweight and Obesity, Metabolic Syndrome
Keywords
Exercise, Strength Training, Health Promotion, Inflammation, Body Composition

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
parallel-group, randomized-controlled study
Masking
Outcomes Assessor
Masking Description
Outcome Assessors involved in data analysis will not be aware of the arm to which the participants were allocated (single-blinded masking).
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control
Arm Type
Experimental
Arm Description
Nutritional therapy / no exercise
Arm Title
Standard Strength Training
Arm Type
Experimental
Arm Description
Nutritional therapy combined with a Standard Strength Training program
Arm Title
Low-volume Strength Training
Arm Type
Experimental
Arm Description
Nutritional therapy combined with a low-volume Strength Training program
Arm Title
Whole-body Electromyostimulation
Arm Type
Experimental
Arm Description
Nutritional therapy combined with Whole-Body Electromyostimulation
Intervention Type
Other
Intervention Name(s)
Control
Intervention Description
Individualized, weight-reducing nutritional therapy and counseling, during a study period of 12 weeks
Intervention Type
Other
Intervention Name(s)
Standard Strength Training
Intervention Description
Procedures: Nutritional therapy (individualized, weight-reducing nutritional therapy and counseling) during a study period of 12 weeks combined with a standard strength training program: 5 strength training exercises (chest, upper/lower back, abdominals, legs) 3 sets per exercise time-effort per session: ~90 min 2 training sessions per week duration of exercise intervention: 12 weeks
Intervention Type
Other
Intervention Name(s)
Low-volume Strength Training
Intervention Description
Procedures: Nutritional therapy (individualized, weight-reducing nutritional therapy and counseling) during a study period of 12 weeks combined a low-volume strength training program: 5 strength training exercises (chest, upper/lower back, abdominals, legs) 1 set per exercise time-effort per session: ~20 min 2 training sessions per week duration of exercise intervention: 12 weeks
Intervention Type
Other
Intervention Name(s)
Whole-Body Electromyostimulation (WB-EMS)
Intervention Description
Procedures: Nutritional therapy (individualized, weight-reducing nutritional therapy and counseling) during a study period of 12 weeks combined with WB-EMS: time-effort per session: ~20 min duration of exercise intervention: 12 weeks
Primary Outcome Measure Information:
Title
Metabolic Syndrome Z-Score (MetS-Z-Score)
Description
MetS-Z-Score will be calculated from each individual's measures of waist circumference, mean arterial blood pressure, triglycerides, and HDL-cholesterol, based on equations specific to sex.
Time Frame
12 weeks (baseline to 12 week follow-up assessment)
Secondary Outcome Measure Information:
Title
Muscle strength
Description
Muscle strength of the five major muscle groups (chest, upper back, lower back, abdominals, legs) will be assessed by using specific strength-training devices (Butterfly, Pull-down, Hyperextension, Abdominal Crunch, Leg-Press)
Time Frame
12 weeks (baseline to 12 week follow-up assessment)
Title
Body Composition
Description
Muscle mass, fat mass and body water will be measured by Bioelectrical Impedance Analysis (BIA)
Time Frame
12 weeks (baseline to 12 week follow-up assessment)
Title
Cardiorespiratory Fitness (CRF)
Description
CRF will be assessed by measuring Maximum Oxygen uptake (VO2max)
Time Frame
12 weeks (baseline to 12 week follow-up assessment)
Title
Inflammation status
Description
Inflammation will be assessed by measuring Levels of CRP and inflammatory cytokines and other inflammatory blood markers
Time Frame
12 weeks (baseline to 12 week follow-up assessment)
Title
Health-related quality of life
Description
Health-related quality of life will be assessed by using the standardized and validated EQ-5D-5L Questionnaire
Time Frame
12 weeks (baseline to 12 week follow-up assessment)
Title
Pain scores
Description
Pain scores will be assessed by using the standardized and validated Chronic Pain Grade Questionnaire (CPGQ)
Time Frame
12 weeks (baseline to 12 week follow-up assessment)
Title
Perceived stress
Description
Perceived stress will be assessed by using the standardized and validated Perceived Stress Questionnaire (PSQ)
Time Frame
12 weeks (baseline to 12 week follow-up assessment)
Title
Subjective work ability
Description
Subjective work ability will be assessed by using the standardized and validated Work Ability Index Questionnaire (WAI)
Time Frame
12 weeks (baseline to 12 week follow-up assessment)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Body Mass Index >25 presence of at least 2 cardiometabolic risk factors Exclusion Criteria: Healthy persons or patients under age Overweight persons without any additional cardiometabolic risk factors Pregnancy, Lactation Psychological disorders, epilepsy, sever neurological disorders Participation in other exercise- or nutrition studies within the last 6 months acute cardiovascular disease malignant disease Rheuma Intake of anabolic drugs, Skin injuries in the area of electrode placements Electronic implants (defibrillator, pacemaker) Persons in mental hospitals by order of authorities or jurisdiction
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Dejan Reljic, Dr.
Phone
+49 9131 8545218
Email
dejan.reljic@uk-erlangen.de
First Name & Middle Initial & Last Name or Official Title & Degree
Yurdaguel Zopf, Prof.
Phone
+49 9131 8545218
Email
yurdaguel.zopf@uk-erlangen.de
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dejan Reljic, Dr.
Organizational Affiliation
University Erlangen Nuremberg Medical School
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Yurdaguel Zopf, Prof.
Organizational Affiliation
University Erlangen Nuremberg Medical School
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Medicine 1, Hector Center for Nutrition, Exercise and Sports,
City
Erlangen
ZIP/Postal Code
91052
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dejan Reljic, Dr.
Phone
+49 9131 8545218
Email
dejan.reljic@uk-erlangen.de
First Name & Middle Initial & Last Name & Degree
Yurdaguel Zopf, Prof.
Phone
+49 9131 8545218
Email
yurdaguel.zopf@uk-erlangen.de

12. IPD Sharing Statement

Learn more about this trial

Whole-body Electromyostimulation Versus Conventional Low-volume Strength Training in Overweight Individuals

We'll reach out to this number within 24 hrs